ReviewArchives of microbiology2025
Recent progress in macrocyclic trichothecene research: structures, biosynthetic pathways, and biological activities.
Review in Archives of microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Macrocyclic trichothecenes are a distinctive class of secondary metabolites produced by Ascomycota characterized by complex macrocyclic scaffolds and diverse biological activities, including antibacterial, antitumor, and immunomodulatory effects. This review provides a comprehensive summary of their classification, biosynthetic pathways, and bioactivities, with a particular focus on research advances from 2015 to 2025. During this period, 30 new macrocyclic trichothecene derivatives have been identified from fungal genera such as Myrothecium, Podostroma, Stachybotrys, Fusarium, and Paramyrothecium. Their biosynthesis is primarily governed by polyketide synthase (PKS) and terpene synthase systems, with key genes such as TRI5 and TRI4 playing central roles. Structural features—including epoxy moieties and side-chain modifications—have been shown to significantly influence their biological activities. In this review, we emphasize newly discovered compounds and recent insights into their biosynthetic mechanisms as well as the anticancer capabilities of different compounds, aiming to provide a valuable reference for future research on the development, optimization, and application of macrocyclic trichothecene derivatives in medical and agricultural contexts.
Indexed as
Identifiers
40906220What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.